Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise.

At Lilly, we make a difference for people the world over by discovering, developing and delivering the breakthrough medicines that help them live longer, healthier more active lives. What’s more, you can also count on us and our people to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism and a creative and innovative can-do spirit.

Post : Regulatory Writer

AbbVie announced the launch of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia (excessive movement) or dyskinesia (involuntary movement), and when available combinations of Parkinson's medicinal products have not given satisfactory results.

Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO) Sub Zonal office and Central Drug Testing Laboratory (CDTL) in Indore, Madhya Pradesh today.

With the launch of ICD 11, Traditional Medicine Module 2 by the World Health Organization today, preparations have started for its implementation. The data and terminology relating to diseases based on Ayurveda, Siddha and Unani Medicine have been included in the WHO ICD-11 classification. With this effort, the terminology defining diseases in Ayurveda, Unani and Siddha medicine has been indexed as a code and included in the WHO Disease Classification Series ICD-11.

Indian Council of Medical Research (ICMR) is an Autonomous Organization, under the Department of Health Research, Ministry of Health & Family Welfare, Govt, of India. ICMR is dealing with biomedical/ health research in various areas, in collaboration with national/ international agencies, through its Headquarters at New Delhi and 27 Institutes / Centres and a large number of field stations, situated across the country.

Post : Consultant (Medical/ Non- Medical)

It is the determination and unrelenting efforts of these trustees towards the fulfillment of Their Holiness' desire that saw the establishment of Sri Sankaradeva Nethralaya in Guwahati. It was the kind gesture of a philanthropic tea-planter Sri Dipankar Chatterjee of Kolkata to donate his building to the Trust for this purpose. The grand alliance of few like-minded doctors headed by Dr.

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

The Laboratory was established in 1941 as a research and production centre, known as Drug Research Laboratory of J&K State and was later taken over by Council of Scientific & Industrial Research (CSIR) of Govt. of India in December 1957 as Regional Research Laboratory, Jammu. In view of its core strength in natural products based drug discovery, the mandate of Institute was redefined in 2005 and its name changed to Indian Institute of Integrative Medicine (IIIM).

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines.

HIRING FOR REGULATORY AFFAIRS IN PLANT OR QA DOCUMENTATION

Post : Executive / Sr. Executive

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Post : Officer / Senior Officer (OSD / Injectables & Ophthalmic)

Centaur Pharmaceutical is the largest specialty of drug manufacturing Organization. We provide high quality affordable medicines trusted by healthcare professionals like USFDA and MHRA. We are one of the rapidly growing Pharmaceutical Company in India. To keep pace with our growth plan, we required young and energetic professionals for our Pune site, having experience in Formulation / Oral solid dosage.

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Infosys Limited is an Indian multinational information technology company that provides business consulting, information technology and outsourcing services. The company was founded in Pune and is headquartered in Bangalore.

 Post : Regulatory and Clinical Business Analyst

GSK plc and Aiolos Bio, Inc announced that they have entered into an agreement under which GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with certain respiratory and inflammatory conditions, for a 1 billion USD upfront payment and up to 400 million USD in certain success-based regulatory milestone payments.

Astellas Pharma Inc. announced the U.S. Food and Drug Administration (FDA) issued a complete response letter on January 4, 2024, regarding the Biologics License Application (BLA) for zolbetuximab, an investigational agent for the treatment of patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.2 positive.

Pfizer Inc announced that the European Commission (EC) has approved TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) in whom chemotherapy is not clinically indicated. With this approval, TALZENNA is now the first and only PARP inhibitor licensed in the European Union for use with XTANDI for patients with mCRPC, with or without gene mutations.

Mayo Clinic Platform, a collaborative ecosystem for healthcare innovation, and Techcyte, a world leader in AI-based digital pathology, are working together to transform the global practice of pathology through the creation of a digital pathology platform.